PT-141

PT-141 (bremelanotide) is a synthetic cyclic melanocortin peptide studied as an agonist of melanocortin receptors, including MC3R and MC4R. Research examines receptor pharmacology and downstream signaling. For laboratory research and analytical use only. Not intended for human or veterinary use, diagnosis, treatment, prevention, mitigation, or cure of any disease. No therapeutic or performance claims are made. Researchers are responsible for appropriate handling, institutional review, and compliance with all applicable laws and regulations.